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Abstract 
 
 Folate receptors have two glycosyl phosphatidylinositol anchored isomers, alpha and 
beta. Folate receptor alpha binds with high affinity for folic acid and act as a receptor for 
mediated transport of folate into the cells. Folate is necessary for DNA metabolism and thus it is 
speculated that rapidly dividing cancer cells have an increased necessity for folic acid. Folate 
receptor alpha levels eminent in specific malignant diseases (like solid tumors and leukemia) and 
thus folate receptors serve in the detection of FR+ (Folate receptor positive) and diagnosis of 
cancers
1-3
.  
          In general, liposomes have the capacity intake the most imaging and toxic agents due to 
their large diameter size (100nm). In the liposomal system, the most important thing for 
therapeutic activity is the conjugation between the liposome and folic acid due to the: 
1. Need to present folate to the cancer cell surface unfettered from the bulky liposome (in 
order to bind to the folate surface). 
2. Need to have sufficient folate ligands for proficient binding to cell but not much more 
folate molecules that could result in non-specific binding.  
          In the liposomal system, folate is attached to poly ethylene glycol (PEG), which is 
incorporated into the lipid membrane by way of a hydrophobic tail. Although widely established, 
liposomes require a fair degree of technical ability to synthesize and analyze. Recently, it has 
been revealed that apoferritin (iron transport protein), 450 kD polymeric protein (at 70 nm in 
diameter), is capable of being dissociated into its respective subunits at low pH 2 and re-
associated at pH around 8.5 to restructure the apoferritin cage for therapeutic purposes. Based on 
all these results, our project aim is to synthesize a folate based apoferritin probe
4-5
. The type of 
folate conjugation to the apoferritin, the degree of folate labeling to the protein, the quantity of 
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dye incorporation into the protein cage and type of dye, drugs and other agents will be assessed 
and ultimately be tested for cell uptake. These types of cages are useful for the production of 
radio-imaging agents, MRI contrast agents and some drug delivery systems. The main goal of 
this project is to make an economical and easily produced folate probe that will be substituted for 
more costly and cumbersome liposome delivery vehicles
6
.  
Introduction 
 
New Clinical research presents the importance of folate receptor in the targeted drug 
delivery system. Targeted deliveries via selective cellular marker can increase the usefulness and 
diminish the toxicity of therapeutic drugs. Folate receptors are richly present in cancer cells, 
helping to deliver the chemotherapeutic agents at specific sites of action and also preventing to 
rich in to the healthy cell. The most important thing for therapeutic activity of the drug is the 
folate receptor drug delivery system link between the drug and folic acid. Strong bonds like 
amide show no or little activity whereas weak bonds like disulfide bonds show strong activity
7-8
.   
Folic Acid: 
 
          Folic acid (vitamin B9) is a water soluble vitamin (see figure 1). The human body requires 
folic acid to generate healthy red blood cells and prevent anemia. Folic acid is important for cell 
division and growth. Folic acid itself is inactive in the body but the reduced form of folic acid is 
tetrahydrofolate that essentially important in the metabolic reactions of the body. It helps in fetal 
development in pregnant women as it develops cells of the fetus. It is also important as a 
coenzyme in the synthesis of DNA and RNA
9-10
.  
          Folate is required in the metabolism of amino acids like histidine, serine, glycine and 
methionine. If folate is not present in methionine metabolism, homocysteine builds up. Excess 
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amount of homocysteine increases the risk of various diseases, particularly cardiovascular 
disease. Homocysteine metabolism also needs vitamin B12 and vitamin B6. Folic acid with 
vitamin B12 causes the conversion of homocysteine to methionine, reducing the blood levels of 
homocysteine and decreasing the risk of heart diseases
11
. Deficiency of folic acid may create 
many health problems such as impaired DNA synthesis, cancer development, and cardiovascular 
disease
12
. Normal diets including leafy foods, liver products, and cereals contain high amounts of 
natural folate and may decrease the risk of cancer
13
. 
Apoferritin cages: 
 
          Apoferritin is nothing but ferritin not combined with iron. Apoferritin is composed of the 
same protein shell as ferritin, but it’s core is empty. Apoferritin has protein spheres found mainly 
in the liver and spleen, research interests has increased due to interesting structure features and 
biological properties. Apoferritin is a native protein containing 24 subunits of polypeptide that 
interact to gather to form a hollow cage like structure with a 12.5 nm diameter. The interior 
cavity of apoferritin has approximately an 8 nm diameter and an interior volume capacity up to 
4500 iron atoms as an iron oxide hydroxide mineral. Apoferritin channels formed by subunit 
interactions with diameter of 3-4 A
0
, connect with each other at the outside of the apoferritin 
molecule
6, 14
.  
          The apoferritin cage can be dissociated into 24 subunits at pH 2 and subunits reconstitute 
at high pH 8.5. Apoferritin, having unique cavity structure as well as its dissociation and 
reconstitution characteristics, has been widely used as a protein cage to synthesize size restricted 
bioinorganic nanocomposite, e.g., cobalt, manganese, iron sulfide, iron phosphate, cadmium 
sulfide, uranium. The application of the synthesized bioinorganic nanocomposite include 
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magnetic resonance imaging, radio pharmaceutical, quantum dots, nanobatteries, uranium 
neutron captured therapy, photo catalysts and magnetic memory devices
15
.     
Appearance of folate receptor: 
 
          The α, β and γ are the three main isoforms of folate receptor. The most widely expressed 
isoforms of folate receptor are α and β. The folate receptor α is expressed at high levels in 
several tissues that include; proximal tubules in the kidney, pneumocytes, intestinal membrane 
and placenta
16-17. The folate receptor β is expressed in low to reasonable amounts in normal 
tissues.  
Folate receptors in the cells 
 
          Folate receptor α is a glycophosphatidylinositol (GPI) membrane bound protein having 
high affinity for folic acid and transport receptor mediated folate in the cells (see figure-2). 
Folate is a basic component for DNA synthesis and its repair. It is hypothesized that rapidly 
dividing cancer cells have an increased requirement for folate to maintain DNA synthesis
18
. 
Folate receptors α level are high in specific malignant tumors of epithelial origin compared to 
normal cells. Folate receptors are over expressed on some cancer cell types but present in low 
abundance in non cancerous tissue. Based on this over expression of the folate receptor, folate 
based drug delivery and diagnostic systems are in several stages of development
19-20
.  
Folate targeted Apoferritin cages: 
 
Folate targeted apoferritin cages can be made in two different ways; 
1. First, apoferritin cages are loaded with folate cysteine and then the pH is lowered to 2 by 
adding 0.1M HCl. Fluorescein sample is loaded into it and pH rises to 8.5 by adding 
0.1M NaOH, The apoferritin cages would trap the fluorescein during reconstitution (see 
figure-13).  
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2. Another way is the apoferritin cage can be dissociated by lowering pH to 2 by adding 
0.1M HCl and loading it with fluorescein sample and then increasing the pH by adding 
0.1M NaOH and loading it with folate cysteine, as the last step.   
           The apoferritin surface has exposed lysine residue. The lysine residue can be coupled with 
folate by combination of a hetero bifunctional crosslinker like SPDP with subsequent addition of 
folate cysteine. We established specific strategy to join folic acid to the apoferritin molecule.  
                                           
Materials, Methods and Instruments 
 
Materials and reagents: 
 
Apoferritin: Apoferritin from Equine spleen, 2.2 ml – 48mg protein/ml, Lot # A3641 
                 Apoferritin from Horse spleen, 25 mg/ml in 50% glycerol & 0.075M NaCl. 
Phosphate Buffer Saline (PBS): Mediatech Inc, Manassas, VA 20109, Lot # 21040174  
Cat no. 21-040-CV; BCA 1-1 kit: Bicinchoninic Acid kit for protein determination, Sigma 
Aldrich, Lot # 059K9801, Bicinchonic Acid Solution: Batch # 118K5300, Copper (II) Sulfate 
Solution: Batch # C2282 (25ml); SPDP (N- Succinimidyl – 3-(2-Pyridyldithio) Propionate, 
Pierce, Lot # HB101395, Prod # 21857; DMSO: Sigma Aldrich, 99% purity, Batch # 11696 DK; 
Fluorescence Sodium Salt (C20H10Na2O5): Sigma-Aldrich, Lot # 079K0141V; Folate Cysteine: 
Provided by Dr. Henne; Water: B & J brand, Lot # CZ 360; Multichannel Pipette : RAININ, 20-
300µl; UV Plate: BD Falcon micro test 96 well 370µl clear plate, UV – VIS transparent film 
bottom, Non-sterile, Lot # E10002007; Regular plate: Generic Bio-One – micro plate, 96 each 
well with flat bottom, Lot # E091006L (see figure-11); Spin Filters: Sigma Aldrich, Amicon 
ultra 0.5 centrifugal filter, Batch # 3110; PD-10 Column: Sephadex G-25M column, contains 
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0.15% Kathon CG in distilled water, Lot # 393861; Centrifuge: Beckman CS-15R and new one 
Thermo scientific Sorvall Legend Micro 17 Ventilated micro centrifuge with 24 place rotor, 
120VAC (see figure-7); UV plate reader and BCA assay Software: Gen 5.1.10 Biotech, Epoch; 
Ocean optics USB 2000+ (for fluorescence study); Ocean optics PX-2, pulsed xenon light 
source; 1 cm cuvette holder .  
                                                       
Methodology 
SPDP labeling with folate cysteine:  
 
        SPDP (N-Succinimidyl–3-(2-Pyridyldithio)-propionate) reagent is an amine and sulfhydryl 
reactive heterobifunctional crosslinker. It forms amine-amine or amine-sulfhydryl crosslinker 
with molecules. Folic acid links with apoferritin cage by heterobifunctional crosslinker SPDP 
(see figure-12). Weight 0.0021gm of SPDP dissolved in 380µl of DMSO. Take only 50µl of this 
solution (SPDP+DMSO) and add to apoferritin sample (100µl of Apoferritin + 400µl of PBS). It 
is allowed to react for 1 hour. After completion of this reaction, the protein cage purifies from 
excess SPDP using spin filters. Spin it for 4 to 5 times with PBS and extracted with PBS 
(Sample-1). Weigh 1.6mg of folate and quickly dissolve in DMSO. Mix this sample with 
sample-1. Again spin it for 4-5 times and extract with H2O. Determination of folic acid on the 
protein was measured in UV-Vis plate at 363nm. 
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Fluorescein Loading: 
 
           Fluorescein loading can be done either with folate or without folate for different purposes. 
First dilute 100µl of apoferritin sample into 400µl of PBS. Wash 3 times with PBS to get rid of 
glycerol. Lower the pH of the solution by 2 by adding 0.1M HCl. Load the fluorescein and stand 
1
•Take 100µl of Apoferritin sample and dilute it to 400µl with PBS
2
• Wash it twice with PBS
3
• Take 21mg of SPDP and dilute it with 380µl of DMSO
4
• Add this solution to the mixture of apoferritin and PBS sample
5
• Place on magnetic stirrer for 1 hour
6
• Wash it 4 times and extract with PBS
7
• Weigh 16mg of folate cysteine and quickly dissolve in DMSO
8
• Mix this solution with the extracted solution of protein 
9
• Spin it 4 times with dis. H2O and extract with dis. H2O
10
• Next step is the fluorescein loading 
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the solution for approximately 15 minutes. Again raise the pH to 8.5 by adding 0.1M NaOH. The 
next step is BCA assay.  
  
Fluorescence study: 
 
          Determination of loading amount of marker (fluorescence sodium salts) in apoferritin can 
be done by simple fluorescence study. The number of entrapped fluorescence was estimated by 
1
•Take 100µl of Apoferritin sample and dilute it with 400µl of dis. H2O
2
• Spin and filter it three times with PBS and keep it magnetic stirring
3
• Take 20mg of fluorescein and dilute it with 5ml dis.H2O(10mM). Make 
10 fold sample (total volume 500µl).
4
• After three washes, lower the apoferritin solution's pH~2 by adding 
156µl of 0.1M HCl
5
• Add 50µl of fluorescein solution to the apoferritin solution
6
• Allow to stand for half an hour
7
• Raise the pH of the solution to 8.5 by adding 140µl of NaOH
8
• Magnetic stir for 2 hours
9
• Spin 4 times with PBS and extract with PBS or run through PD 10 
column
10
• Do the BCA Assay  for collected fractions
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calibrating the ratio of concentration of fluorescence and apoferritin. Bicinchoninic acid method 
can be used for the apoferritin concentration measurement. The fluorescein content in apoferritin 
can be determined by comparing fluorescence intensities of the fluorescein Marker-Loaded 
apoferritin nanoparticles with standard fluorescein solution. By measuring fluorescence 
intensities of fluorescein solution at different concentrations, a calibration curve for the standard 
fluorescein was developed
6
.  
Preparation of different dilutions of fluorescein sodium salt:  
 
 
BCA Assay:    
 
           The apoferritin concentration can be measured by using the bicinchoninic acid method. 
BCA protein assay is a detergent compatible formulation based on BCA for colorimetric 
1
• Weigh 1.9mg of fluorescein and dissolve into 5ml of PBS (Sample-1)
2
• Sample-2: Take 500µl from sample-1 & add 4.5ml of PBS 
3
• Sample-3: Take 500µl from sample-2 & add 4.5ml of PBS 
4
• Sample-4: Take 1ml from sample-3 & add 4ml of PBS 
5
• Sample-5: Take 1ml from sample-4 & add 4ml of PBS 
6
• Sample-6: Take 1ml from sample-4 & add 1ml of PBS 
7
• Sample-7: Take 1ml fromsample-5 & add 1ml of PBS 
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detection and quantitation of protein. Bovine serum albumin (BSA) stock solution was taken 
from ampoule and different dilutions prepared as per Thermo Scientific Pierce BCA protein 
assay instructions. Prepare different dilutions 2000µg/ml, 1500µg/ml, 1000µg/ml, 750µg/ml, 
500µg/ml, 250µg/ml, 125µg/ml, 25µg/ml and 0µg/ml for BCA assay. By using 96-micowell 
plate, take 10µl of each standard solution as well as unknown by duplicates in each well. Then 
added 200µl of the working prepared solution (10ml of BCA solution and 200µl of Cu (II) 
sulphate solution and mixed it in a tube). Incubate the 96-microwell plate for half an hour and 
find out the concentration by using the BCA Assay Gen 5.0 software (see figure-11).  
Results and Discussion 
 
Folate Labeling:  
 
          The method used here for folate labeling with SPDP crosslinker was straightforward and 
quick. Labeling of protein with folate was carried out with specific concentration of folate by 
using SPDP crosslinker. With the molar extinction coefficient of folic acid at pH 7.5, we 
determined the degree of folate labeling was approximately 100. There were 4 exposed lysine 
units found on the apoferritin cage surface which means approximately 96 (4*24) residues were 
conjugatable. Our results explain that we could label approximately 96 sites and almost got full 
folate labeling (see figure-13).  
BCA Assay: 
 
          Bicinchoninic acid method was used for the measurement of apoferritin concentration. 
This method employs the reduction of Cu
+2 
to Cu
+1
 by protein in alkaline medium with the 
highly selective and sensitive colorimetric detection of the Cu
+1
 by using bicinchoninic acid 
reagent. The chelation of two molecules of BCA with Cu
+1
 creates a purple colored reaction that 
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absorbs at 562nm. The amount of product formed is nearly linear with increasing protein 
concentrations over a broad working range (0 - 1500µg/ml).  
          Upon final purification using the spin filter method, the compound was analyzed for 
protein concentration using BCA assay. Based on the BCA assay reading, we determined the 
apoferritin concentration to be 2191mg/ml (see figure-11 and figure-14). 
Fluorescein Loading (Fluorescence Study): 
 
          The ratio of the concentrations of markers (fluorescein sodium salt and Methylene blue) 
and apoferritin cage can help to estimate the number of entrapped markers. Attempts to increase 
the loading of fluorescein sodium salt have been undertaken.  
          By using the concentration of protein from BCA assay and concentration of fluorescein 
from fluorescence study, we determined fluorescein loading of 1 or 2 
          A calibration curve for the standard fluorescein was developed by measuring fluorescence 
intensities at the different concentration of fluorescein. We got liner graph (R
2
 = 0.9992) with 
fluorescence study (see figure-18 and figure-19).  
 
Conclusions: 
          Folate labeling and fluorescein loading with apoferritin is prepared using a very 
straightforward and secure methodology using very simple instrumentations. First we conjugated 
folate to the apoferritin cage and then determined the degree of labeling to the protein. Purified 
protein cages were loaded with folate using spin filters. We attempted to load the protein with 
fluorescein dye and determined the degree of dye incorporation. We tried to trap the fluorescein 
with apoferritin cage by using different concentrations. We succeeded in fluorescence 
spectroscopy by using different concentration of fluorescein. 
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Future Studies 
 
Increase fluorescein loading and test the apoferritin protein cages with folate receptor positive 
cancer cells.  
Load the apoferritin cage with other agents such as methylene blue for photodynamic therapy 
and/or chemotherapeutic agents such as cis-platin.  
Funding 
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Figure 1: Structure of folic acid 
 
 
 
 
Figure 2: Folate receptor pathway and FR-mediated endocytosis of a folic acid drug conjugates. 
Folate conjugates bind folate receptor with high affinity and then internalized into endosomes 
that can reduce disulfide bonds. (Figure taken from Accounts of chemical research 120-129 
January 2008 Vol. 41, No.1) 
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Figure 3: Comparison of alpha-FR on normal cells and malignant cells. (Endocyte Inc.) 
 
 
                         
Figure 4: SPDP Structure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                    
 Figure 5: DMSO (Dimethyl Sulfoxide) 
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Figure 6: Fluorescein Sodium Salt (C20H10Na2O5)         
 
 
 
 
                                           
 
Figure 7: Thermo scientific Sorvall Legend Micro 17 Ventilated micro centrifuge with 24 place 
rotor, 120VAC (8898 RPM for 12 minutes) 
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Figure 8: pH meters 
 
 
 
                                     
                           
Figure 9: Magnetic Stirrer 
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Figure 10: Folate labeling and fluorescein loading to apoferritin cage after final spin filter. 
 
 
 
Figure 11: Generic Bio-One, 96-microwell plate, after 1 hour incubation while doing BCA 
Assay 
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Figure 12: SPDP Labeling and folate labeling 
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Figure 13: Folate labeling and fluorescein loading with apoferritin 
 
 
 
 
 
Figure 14: BCA Assay 
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Figure 15: UV-Vis Spectrum of apoferritin 
 
 
 
 
Figure 16: UV-Vis Spectrum of Folate 
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Figure 17: UV-Vis Spectrum of apoferritin + folate 
 
  
Figure 18: Apoferritin loaded with fluorescein 
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Figure 19: Fluorescence study  
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